Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1091220223Not yet recruiting
Randomised, open-label trial of teneligliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bonpei Takase. Primary endpoint: endothelial function. Planned start Aug 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1091220223.